Morris A J, Panchatcharam M, Cheng H Y, Federico L, Fulkerson Z, Selim S, Miriyala S, Escalante-Alcalde D, Smyth S S
The Gill Heart Institute, Division of Cardiovascular Medicine, Lexington, KY, USA.
J Thromb Haemost. 2009 Jul;7 Suppl 1(Suppl 1):38-43. doi: 10.1111/j.1538-7836.2009.03405.x.
Lysophosphatidic acid (LPA), its sphingolipid homolog sphingosine 1-phosphate (S1P) and several other related molecules constitute a family of bioactive lipid phosphoric acids that function as receptor-active mediators with roles in cell growth, differentiation, inflammation, immunomodulation, apoptosis and development. LPA and S1P are present in physiologically relevant concentrations in the circulation. In isolated cell culture systems or animal models, these lipids exert a range of effects that suggest that S1P and LPA could play important roles in maintaining normal vascular homeostasis and in vascular injury responses. LPA and S1P act on a series of G protein-coupled receptors, and LPA may also be an endogenous regulator of PPARgamma activity. In this review, we discuss potential roles for lysolipid signaling in the vasculature and mechanisms by which these bioactive lipids could contribute to cardiovascular disease.
溶血磷脂酸(LPA)、其鞘脂同系物鞘氨醇-1-磷酸(S1P)以及其他几种相关分子构成了一类生物活性脂质磷酸,它们作为受体活性介质,在细胞生长、分化、炎症、免疫调节、细胞凋亡和发育中发挥作用。LPA和S1P在循环系统中以生理相关浓度存在。在分离的细胞培养系统或动物模型中,这些脂质发挥一系列作用,表明S1P和LPA可能在维持正常血管稳态和血管损伤反应中发挥重要作用。LPA和S1P作用于一系列G蛋白偶联受体,并且LPA也可能是PPARγ活性的内源性调节剂。在这篇综述中,我们讨论了溶血磷脂信号在脉管系统中的潜在作用以及这些生物活性脂质可能导致心血管疾病的机制。